These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Bar-Zeev N; Kapanda L; Tate JE; Jere KC; Iturriza-Gomara M; Nakagomi O; Mwansambo C; Costello A; Parashar UD; Heyderman RS; French N; Cunliffe NA; Lancet Infect Dis; 2015 Apr; 15(4):422-8. PubMed ID: 25638521 [TBL] [Abstract][Full Text] [Related]
45. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. Braeckman T; Van Herck K; Meyer N; Pirçon JY; Soriano-Gabarró M; Heylen E; Zeller M; Azou M; Capiau H; De Koster J; Maernoudt AS; Raes M; Verdonck L; Verghote M; Vergison A; Matthijnssens J; Van Ranst M; Van Damme P; BMJ; 2012 Aug; 345():e4752. PubMed ID: 22875947 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Vesikari T; Karvonen A; Ferrante SA; Ciarlet M Eur J Pediatr; 2010 Nov; 169(11):1379-86. PubMed ID: 20559656 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136 [TBL] [Abstract][Full Text] [Related]
48. Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany. Pietsch C; Liebert UG Clin Microbiol Infect; 2019 Jan; 25(1):102-106. PubMed ID: 29649603 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of the oral pentavalent rotavirus vaccine in Mali. Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140 [TBL] [Abstract][Full Text] [Related]
50. Effectiveness of Lanzhou Lamb Rotavirus Vaccine and RotaTeq Against Hospitalized Rotavirus Infections Among Children During 2020-2023 in Guangdong Province, China: A Test-Negative Case-Control Study. Yi Y; Liu J; Zhang Y; Zeng B; Lin L; Li C; Yang F; Zhang H; Xie R; Huang Z; Kang M; Jiang Y Infect Dis Ther; 2024 Nov; 13(11):2301-2317. PubMed ID: 39283583 [TBL] [Abstract][Full Text] [Related]
51. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Field EJ; Vally H; Grimwood K; Lambert SB Pediatrics; 2010 Sep; 126(3):e506-12. PubMed ID: 20732946 [TBL] [Abstract][Full Text] [Related]
52. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. Velázquez RF; Linhares AC; Muñoz S; Seron P; Lorca P; DeAntonio R; Ortega-Barria E BMC Pediatr; 2017 Jan; 17(1):14. PubMed ID: 28086819 [TBL] [Abstract][Full Text] [Related]
53. Cost effectiveness of a pentavalent rotavirus vaccine in Oman. Al Awaidy ST; Gebremeskel BG; Al Obeidani I; Al Baqlani S; Haddadin W; O'Brien MA BMC Infect Dis; 2014 Jun; 14():334. PubMed ID: 24941946 [TBL] [Abstract][Full Text] [Related]
54. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Fu C; Wang M; Liang J; He T; Wang D; Xu J Vaccine; 2007 Dec; 25(52):8756-61. PubMed ID: 18023510 [TBL] [Abstract][Full Text] [Related]
56. Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia. Sanneh B; Papa Sey A; Shah M; Tate J; Sonko M; Jagne S; Jarju M; Sowe D; Taal M; Cohen A; Parashar U; Mwenda JM Vaccine; 2018 Nov; 36(47):7179-7184. PubMed ID: 29544688 [TBL] [Abstract][Full Text] [Related]
57. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo. Tsolenyanu E; Djadou KE; Fiawoo M; Akolly DAE; Mwenda JM; Leshem E; Tate JE; Aliabadi N; Koudema W; Guedenon KM; Godonou M; Dagnra A; Gbadoe AD; Boko A; Landoh D; Atakouma Y; Parashar UD Vaccine; 2018 Nov; 36(47):7185-7191. PubMed ID: 29397224 [TBL] [Abstract][Full Text] [Related]
58. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua. Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age. Li J; Zhang Y; Yang Y; Liang Z; Tian Y; Liu B; Gao Z; Jia L; Chen L; Wang Q Vaccine; 2019 Jun; 37(27):3611-3616. PubMed ID: 31122857 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]